Task: Answer the multiple-choice question.
Question: Which drug exhibits a 17.086\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a O=C(COC(=O)COc1ccccc1)Nc1ccccc1OC(F)F
b CCc1cc2c(SCC(=O)C(C#N)=C3N(C)c4ccccc4N3C)ncnc2s1
c COc1cccc(N2CCN(C(=O)/C=C/c3ccco3)CC2)c1
d CCn1cc(CN2CCC(n3nccc3NC(=O)C3CCCC3)CC2)cn1
Answer: d. CCn1cc(CN2CCC(n3nccc3NC(=O)C3CCCC3)CC2)cn1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCn1cc(CN2CCC(n3nccc3NC(=O)C3CCCC3)CC2)cn1
CCn1cc(CN2CCC(n3nccc3NC(=O)C3CCCC3)CC2)cn1
N-[2-[1-[(1-ethylpyrazol-4-yl)methyl]piperidin-4-yl]pyrazol-3-yl]cyclopentanecarboxamide